The global gene expression market size is expected to reach USD 13.36 Billion in 2028 at a CAGR of 8.1% during the forecast period, according to the latest report by Reports and Data. Increasing application of gene expression profiling to detect variants of COVID-19, rapid advancements in genomics and proteomics research, and growing investments to accelerate development of robust gene expression databases are key factors expected to drive market revenue growth over the forecast period. In addition, increasing focus on development of personalized medicines and growing need to streamline the workflow of genetic analysis are some other key factors expected to boost revenue growth of the market going ahead.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1474
The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, the growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. A combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription has significantly contributed to the revenue growth of the market.
Research Methodology:
Reports and Data utilizes a unique approach to research to offer a comprehensive overview of the global Gene Expression Market to offer insights into investment opportunities for stakeholders, investors, clients, and businesses to make informed decisions. The report includes SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis to offer a better understanding of the market scenario.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1474
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Some Key Highlights from the Report:
- Services segment is expected to register significantly fast revenue growth rate over the forecast period attributed to growing demand for high-end gene expression profiling and bioinformatics services, in dose-limited toxicity studies, and availability of wide range of RNA-seq profiling services.
- High-Plex capacity segment is expected to account for largest revenue share over the forecast period owing to rising availability of high-throughput and fast multiplex gene analysis for multiplexes expression quantitation, increasing benefits of high-plex gene expression in drug research and biomarkers discovery, and introduction of efficient and affordable multiple solutions.
- Clinical diagnostic segment is expected to account for a considerably large revenue share over the forecast period attributable increasing application of gene expression analysis and profiling for early and precise diagnosis of genetic disorders, to understand the disease pathogenesis, and in tracking the progression of disease and its response to therapeutic approaches.
- North America is expected to account for largest revenue share in the global market between 2021 and 2028 attributable to increasing availability of more advanced research facilities, rising prevalence of genetic disorders, growing focus on development of personalized medicines, and increasing investments to accelerate genomics and proteomics research.
- Major companies profiled in the global market report include Agilent Technologies, QIAGEN N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Oxford Gene Technology, GE Healthcare, F. Hoffmann-La Roche AG, and Becton, Dickinson, and Company.
Request customization on the report @ https://www.reportsanddata.com/request-customization-form/1474
For the purpose of this report, Reports and Data has segmented the global gene expression market based on product and services, capacity, application, and region:
Product & Services Outlook (Revenue, USD Billion; 2018-2028)
- Instrument
- PCR
- NGS
- DNA Microarray
- Others
- Consumables
- Reagents
- DNA Chips
- Services
- Gene Expression Profiling Services
- Sequencing Services
- Other Services
- Bioinformatics Solutions
- Gene Expression Profiling Services
Capacity Outlook (Revenue, USD Billion; 2018-2028)
- Low- To Mid- Plex Gene Expression Analysis
- High-Plex Gene Expression Analysis
Application Outlook (Revenue, USD Billion; 2018-2028)
- Clinical Diagnostics
- Drug Discovery & Development
- Biotechnology Research
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Press Release Available@https://www.reportsanddata.com/press-release/global-gene-expression-market
Explore Latest Trending Research Reports By Reports and Data:
Uveitis Market @ https://www.biospace.com/article/uveitis-market-study-on-current-status-and-challenges-with-future-opportunities-to-2030/
Trichomoniasis Market @ https://www.biospace.com/article/trichomoniasis-market-research-by-business-growth-analysis-industry-strategy-and-development-to-2030/
Transverse Myelitis Market @ https://www.biospace.com/article/transverse-myelitis-market-analysis-on-new-growth-startegies-with-upcoming-trends-and-forecast-to-2030/
Tonsillitis Market @ https://www.biospace.com/article/tonsillitis-market-to-showcase-strong-cagr-between-2022-and-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos